HomeCompareBSMV vs JNJ

BSMV vs JNJ: Dividend Comparison 2026

BSMV yields 2.94% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BSMV wins by $4.1K in total portfolio value
10 years
BSMV
BSMV
● Live price
2.94%
Share price
$20.88
Annual div
$0.61
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.1K
Annual income
$355.66
Full BSMV calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BSMV vs JNJ

📍 BSMV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSMVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSMV + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSMV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSMV
Annual income on $10K today (after 15% tax)
$250.10/yr
After 10yr DRIP, annual income (after tax)
$302.31/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $401.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSMV + JNJ for your $10,000?

BSMV: 50%JNJ: 50%
100% JNJ50/50100% BSMV
Portfolio after 10yr
$22.1K
Annual income
$591.72/yr
Blended yield
2.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BSMV
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSMV buys
0
JNJ buys
0
No recent congressional trades found for BSMV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSMVJNJ
Forward yield2.94%3.36%
Annual dividend / share$0.61$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.1K$20.0K
Annual income after 10y$355.66$827.78
Total dividends collected$3.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BSMV vs JNJ ($10,000, DRIP)

YearBSMV PortfolioBSMV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,994$294.23$10,676$355.77+$318.00BSMV
2$12,066$302.32$11,407$389.39+$659.00BSMV
3$13,221$310.09$12,198$426.53+$1.0KBSMV
4$14,464$317.54$13,056$467.62+$1.4KBSMV
5$15,801$324.66$13,987$513.12+$1.8KBSMV
6$17,239$331.48$14,998$563.56+$2.2KBSMV
7$18,783$337.97$16,098$619.52+$2.7KBSMV
8$20,442$344.17$17,295$681.69+$3.1KBSMV
9$22,223$350.06$18,599$750.82+$3.6KBSMV
10$24,135$355.66$20,022$827.78+$4.1KBSMV

BSMV vs JNJ: Complete Analysis 2026

BSMVStock

The Invesco BulletShares 2031 Municipal Bond ETF (Fund) is based on the Invesco BulletShares USD Municipal Bond 2031 Index (Index). The Fund will invest at least 80% of its total assets in municipal bonds that comprise the index. The Index seeks to measure the performance of a portfolio of US dollar-denominated municipal securities, issued by US state, state agencies, or local governments with effective maturities in 2031. The Fund does not purchase all of the securities in the Index; instead, the Fund utilizes a "sampling" methodology to seek to achieve its investment objective. The Fund and the Index are rebalanced monthly. The Fund has a designated year of maturity of 2031 and will terminate on or about Dec. 15, 2031. See the prospectus for more information.

Full BSMV Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BSMV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSMV vs SCHDBSMV vs JEPIBSMV vs OBSMV vs KOBSMV vs MAINBSMV vs ABBVBSMV vs MRKBSMV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.